GlassScriptPhysician profile
Dana Leann Mccrary
NPI 1871041715
$560.70
in general payments reported to CMS, 2019-2025
7 companies · $229 in 2025
The $229 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $89.19 · 2022: $76.07 · 2023: $76.39 · 2024: $90.27 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $199 · Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $198.99 |
| Food and Beverage | $196.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $198.99 | 2025 | |
| Novo Nordisk INC | $154.51 | 2021-2024 | Wegovy |
| Lilly USA, LLC | $76.36 | 2024 | Zepbound |
| Genentech USA, INC. | $50.63 | 2021 | |
| Acella Pharmaceuticals, LLC | $29.79 | 2025 | NP Thyroid 60 |
| Novartis Pharmaceuticals Corporation | $26.23 | 2021 | |
| Halozyme INC | $24.19 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Mccrary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.